On Tuesday, PDS Biotechnology Corporation (NASDAQ: PDSB) opened higher 18.00% from the last session, before settling in for the closing price of $0.9. Price fluctuations for PDSB have ranged from $0.70 to $2.28 over the past 52 weeks.
Healthcare Sector giant saw their annual sales surged by 6.42% over the last five years. Company’s average yearly earnings per share was noted 22.33% at the time writing. With a float of $53.08 million, this company’s outstanding shares have now reached $54.72 million.
PDS Biotechnology Corporation (PDSB) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of PDS Biotechnology Corporation is 3.00%, while institutional ownership is 10.30%. The most recent insider transaction that took place on Feb 28 ’25, was worth 25,000. In this transaction Director of this company bought 15,060 shares at a rate of $1.66, taking the stock ownership to the 61,213 shares. Before that another transaction happened on Feb 28 ’25, when Company’s Director bought 15,061 for $1.66, making the entire transaction worth $25,001. This insider now owns 78,851 shares in total.
PDS Biotechnology Corporation (PDSB) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.21 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.28) by 0.07. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.18 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 22.33% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 12.71% during the next five years compared to 6.42% growth over the previous five years of trading.
PDS Biotechnology Corporation (NASDAQ: PDSB) Trading Performance Indicators
Check out the current performance indicators for PDS Biotechnology Corporation (PDSB). In the past quarter, the stock posted a quick ratio of 2.09.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.82, a number that is poised to hit -0.20 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of PDS Biotechnology Corporation (PDSB)
Analysing the last 5-days average volume posted by the [PDS Biotechnology Corporation, PDSB], we can find that recorded value of 0.84 million was better than the volume posted last year of 0.61 million. As of the previous 9 days, the stock’s Stochastic %D was 82.59%.
During the past 100 days, PDS Biotechnology Corporation’s (PDSB) raw stochastic average was set at 46.54%, which indicates a significant decrease from 92.27% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.0720 in the past 14 days, which was lower than the 0.0773 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.9065, while its 200-day Moving Average is $1.1806. Now, the first resistance to watch is $1.1166. This is followed by the second major resistance level at $1.1732. The third major resistance level sits at $1.2565. If the price goes on to break the first support level at $0.9767, it is likely to go to the next support level at $0.8934. Should the price break the second support level, the third support level stands at $0.8368.
PDS Biotechnology Corporation (NASDAQ: PDSB) Key Stats
There are currently 48,980K shares outstanding in the company with a market cap of 58.01 million. Presently, the company’s annual sales total 0 K according to its annual income of -37,610 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -9,010 K.
